According to Bristol-Myers Squibb's latest financial reports the company's current earnings (TTM) are $8.44 B. In 2022 the company made an earning of $7.71 B a decrease over its 2021 earnings that were of $8.09 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $8.44 B | 9.43% |
2022 | $7.71 B | -4.75% |
2021 | $8.09 B | -217.86% |
2020 | -$6.88 B | -238.11% |
2019 | $4.97 B | -16.64% |
2018 | $5.96 B | 16.31% |
2017 | $5.13 B | -13.25% |
2016 | $5.91 B | 184.79% |
2015 | $2.07 B | -12.77% |
2014 | $2.38 B | -17.64% |
2013 | $2.89 B | 23.55% |
2012 | $2.34 B | -66.48% |
2011 | $6.98 B | 14.99% |
2010 | $6.07 B | 20.58% |
2009 | $5.03 B | -7.97% |
2008 | $5.47 B | 74.12% |
2007 | $3.14 B | 19.24% |
2006 | $2.63 B | -41.65% |
2005 | $4.51 B | 2.59% |
2004 | $4.40 B | -10.76% |
2003 | $4.93 B | 86.36% |
2002 | $2.64 B | -6.27% |
2001 | $2.82 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $16.97 B | 101.09% | ๐บ๐ธ USA |
Novartis NVS | $9.43 B | 11.82% | ๐จ๐ญ Switzerland |
Pfizer PFE | $3.26 B | -61.29% | ๐บ๐ธ USA |
AbbVie ABBV | $6.25 B | -25.95% | ๐บ๐ธ USA |
Eli Lilly LLY | $6.55 B | -22.34% | ๐บ๐ธ USA |
Amgen AMGN | $7.85 B | -6.93% | ๐บ๐ธ USA |
Sanofi SNY | $8.39 B | -0.53% | ๐ซ๐ท France |
Biogen BIIB | $1.29 B | -84.64% | ๐บ๐ธ USA |
Merck MRK | $3.03 B | -64.04% | ๐บ๐ธ USA |
AstraZeneca AZN | $8.49 B | 0.65% | ๐ฌ๐ง UK |